ZOE.XETRA Zoetis Inc

Healthcare Pharmaceuticals XETRA Stock Exchange
74.70 EUR
Close of Nov 6, 2026
60.74 112.87
Market cap
EUR 30.9B
P/E
14.2x
P/B
11.42x
ROE
81.9%
Dividend yield
2.54%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ZOE.XETRA undervalued?

Graham number
Price74.70
Graham value27.82
Premium168.5%

ZOE.XETRA trades 168.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zoetis Inc fundamental analysis

No fundamental analysis for Zoetis Inc yet.

Zoetis Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also …

Full company profile